1.
|
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-060-version1a, NCT00338481
|
|
2.
|
Phase: Phase IV
Type: Supportive care, Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: UMCN-AKF 07.02, EudraCTnr 2007-003347-73, NCT00588835
|
|
3.
|
Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 60 to 80
Sponsor: Other
Protocol IDs: PROLOG, NCT00675168
|
|
4.
|
Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2612-3681, NCT00724581
|
|
5.
|
Phase: Phase IV
Type: Treatment
Status: Approved-not yet active
Age: 18
Sponsor: Other
Protocol IDs: P080204, IDRCB 2008-A01386-49, NCT00925444
|
|
6.
|
Phase: Phase III, Phase II
Type: Diagnostic
Status: Active
Age: 15 and over
Sponsor: Other
Protocol IDs: SP-11-0035, NCT00123760
|
|
7.
|
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 001-0015-211, NCT00127387
|
|
8.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: Haema CBF SCLC UK/AS 01, NCT00168896
|
|
9.
|
Phase: Phase III, Phase II
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: FLT101, NCT00847509
|
|
10.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 75
Sponsor: Other
Protocol IDs: IFCT-0802, 2009-010187-42, NCT00930891
|
|
11.
|
Phase: Phase III
Type: Diagnostic
Status: Active
Age: 19 to 90
Sponsor: Other
Protocol IDs: R05-0076, NCT00207298
|
|
12.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005P000376, NCT00300495
|
|
13.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-0517, RTOG 0517, NCT00365105
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRCST-L-0001, NCT00349492
|
|
15.
|
Phase: Phase III
Type: Educational/Counseling/Training, Screening, Treatment
Status: Active
Age: 65 and over
Sponsor: Other
Protocol IDs: IRB00000063, NCT00379743
|
|
16.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRUK-LUNGSTAR, EU-20649, ISRCTN56306957, EUDRACT-2005-005821-71, UCL-BRD/05/129, NCT00433498
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CHNT-CONVERT, CHNT-CTAAC-CONVERT-C17052/A8152, EU-20669, NCT00433563
|
|
18.
|
Phase: Phase III
Type: Health services research
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SWS-SAKK-95/06, SAKK-95/06, EU-20711, SWS-SAKK-E-MOSAIC, NCT00477919
|
|
19.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: WCTU-FRAGMATIC, Velindre-FRAGMATIC, WCTU-02, EU-20753, WCTU-02, PFIZER-WCTU-02, WCTU-FRAGMATIC, EUDRACT-2005-002438-37, ISRCTN80812769, NCT00519805
|
|
20.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-0901, NCT00513357
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 70 and under
Sponsor: Other
Protocol IDs: STAD-1, EudraCT number 2006-003995-36, NCT00526396
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMR PH GL 2007 CL 001, NCT00547651
|
|
23.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: INSYS-INS-05-001, INS-05-001, NCT00538850, NCT00538850
|
|
24.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: INSYS-INS-06-007, INS-06-007, NCT00538863
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CALGB-30610, CALGB 30610, RTOG 0538, NCT00632853
|
